Annual Working Capital
$85.25 M
-$64.38 M-43.02%
December 31, 2023
Summary
- As of February 8, 2025, BOLT annual working capital is $85.25 million, with the most recent change of -$64.38 million (-43.02%) on December 31, 2023.
- During the last 3 years, BOLT annual working capital has risen by +$71.16 million (+504.75%).
- BOLT annual working capital is now -49.20% below its all-time high of $167.83 million, reached on December 31, 2021.
Performance
BOLT Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$39.06 M
-$19.67 M-33.49%
September 30, 2024
Summary
- As of February 8, 2025, BOLT quarterly working capital is $39.06 million, with the most recent change of -$19.67 million (-33.49%) on September 30, 2024.
- Over the past year, BOLT quarterly working capital has dropped by -$19.67 million (-33.49%).
- BOLT quarterly working capital is now -84.93% below its all-time high of $259.20 million, reached on March 31, 2021.
Performance
BOLT Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
BOLT Working Capital Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -43.0% | -33.5% |
3 y3 years | +504.8% | -33.5% |
5 y5 years | +651.5% | -33.5% |
BOLT Working Capital Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -49.2% | at low | -77.9% | at low |
5 y | 5-year | -49.2% | +504.8% | -84.9% | +177.1% |
alltime | all time | -49.2% | +651.5% | -84.9% | +177.1% |
Bolt Biotherapeutics Working Capital History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $39.06 M(-33.5%) |
Jun 2024 | - | $58.73 M(-25.0%) |
Mar 2024 | - | $78.33 M(-8.1%) |
Dec 2023 | $85.25 M(-43.0%) | $85.25 M(-20.1%) |
Sep 2023 | - | $106.72 M(-5.6%) |
Jun 2023 | - | $113.05 M(-2.0%) |
Mar 2023 | - | $115.36 M(-22.9%) |
Dec 2022 | $149.63 M | $149.63 M(-0.7%) |
Sep 2022 | - | $150.65 M(-7.4%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2022 | - | $162.64 M(-8.0%) |
Mar 2022 | - | $176.78 M(+5.3%) |
Dec 2021 | $167.83 M(+1090.6%) | $167.83 M(-15.6%) |
Sep 2021 | - | $198.79 M(-13.2%) |
Jun 2021 | - | $228.90 M(-11.7%) |
Mar 2021 | - | $259.20 M(+1738.7%) |
Dec 2020 | $14.10 M(-48.3%) | $14.10 M(-52.7%) |
Sep 2020 | - | $29.78 M(+9.3%) |
Dec 2019 | $27.24 M(+140.1%) | $27.24 M |
Dec 2018 | $11.35 M | - |
FAQ
- What is Bolt Biotherapeutics annual working capital?
- What is the all time high annual working capital for Bolt Biotherapeutics?
- What is Bolt Biotherapeutics annual working capital year-on-year change?
- What is Bolt Biotherapeutics quarterly working capital?
- What is the all time high quarterly working capital for Bolt Biotherapeutics?
- What is Bolt Biotherapeutics quarterly working capital year-on-year change?
What is Bolt Biotherapeutics annual working capital?
The current annual working capital of BOLT is $85.25 M
What is the all time high annual working capital for Bolt Biotherapeutics?
Bolt Biotherapeutics all-time high annual working capital is $167.83 M
What is Bolt Biotherapeutics annual working capital year-on-year change?
Over the past year, BOLT annual working capital has changed by -$64.38 M (-43.02%)
What is Bolt Biotherapeutics quarterly working capital?
The current quarterly working capital of BOLT is $39.06 M
What is the all time high quarterly working capital for Bolt Biotherapeutics?
Bolt Biotherapeutics all-time high quarterly working capital is $259.20 M
What is Bolt Biotherapeutics quarterly working capital year-on-year change?
Over the past year, BOLT quarterly working capital has changed by -$19.67 M (-33.49%)